Accelera Canada

Toronto, Canada Founded: 2017 • Age: 9 yrs Acquired By EVERSANA
Advocacy, market access, and regulatory services for biopharma are provided.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Accelera Canada

Accelera Canada is a company based in Toronto (Canada) founded in 2017 was acquired by EVERSANA in July 2021. Accelera Canada operates in a competitive market with competitors including Zuellig Pharma, Indegene, IntegriChain, Clinigen and Fabtech, among others.

  • Headquarter Toronto, Canada
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    EVERSANA

    (Jul 26, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Accelera Canada

Premium access

Detailed funding history for Accelera Canada

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Accelera Canada

Accelera Canada has secured backing from 1 investor. Prominent investors backing the company include Eversana.

All
Investor Description Founded Year Domain Location
Drug pricing, access, reimbursement, and regulatory consulting services are provided.
Locked Locked Locked
Premium access

Investor details for Accelera Canada

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Accelera Canada

Investments
Premium access

Investment portfolio details for Accelera Canada

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Accelera Canada

Premium access

Detailed financials for Accelera Canada

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Accelera Canada Comparisons

Accelera Canada Primary company
Description
Advocacy, market access, and regulatory services for biophar...
Location
Toronto, Canada
Founded Year
2017
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Accelera Canada

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Accelera Canada

Accelera Canada operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zuellig Pharma, Indegene, IntegriChain, Clinigen and Fabtech, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Healthcare access in Asia is enhanced by Zuellig Pharma.
Locked Locked Locked
Suite solutions are provided for payers and healthcare providers.
Locked Locked Locked
Inventory, order and customer relationship management solution for life science suppliers.
Locked Locked Locked
Specialty medicines are supplied via clinical trials and access programs.
Locked Locked Locked
Instruments for biotech, pharmaceutical, and biomedical sectors are manufactured.
Locked Locked Locked
Technology-based consultancy and product development services are provided.
Premium access

Detailed competitors of Accelera Canada

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Accelera Canada

Premium access

Complete news archive for Accelera Canada

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Accelera Canada

Accelera Canada was founded in 2017.

Accelera Canada is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.

Accelera Canada was founded in 2017 and is based in Toronto, Canada. Operations focus on the biopharmaceutical sector, where advocacy, market access, and regulatory services are delivered to support client needs. These services assist in navigating regulatory landscapes and enhancing market entry strategies. The company maintains a presence through its domain, acceleracanada.com, serving stakeholders in the industry across relevant geographies.

Accelera Canada's top competitors include Indegene, Zuellig Pharma and IntegriChain.

Accelera Canada has 1 investor. Key investors include Eversana.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available